98 related articles for article (PubMed ID: 10563470)
1. Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase.
Wang SW; Pawlowski J; Wathen ST; Kinney SD; Lichenstein HS; Manthey CL
Inflamm Res; 1999 Oct; 48(10):533-8. PubMed ID: 10563470
[TBL] [Abstract][Full Text] [Related]
2. SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes.
Manthey CL; Wang SW; Kinney SD; Yao Z
J Leukoc Biol; 1998 Sep; 64(3):409-17. PubMed ID: 9738669
[TBL] [Abstract][Full Text] [Related]
3. The differential role of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions.
Adachi T; Choudhury BK; Stafford S; Sur S; Alam R
J Immunol; 2000 Aug; 165(4):2198-204. PubMed ID: 10925307
[TBL] [Abstract][Full Text] [Related]
4. Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade.
Brook M; Sully G; Clark AR; Saklatvala J
FEBS Lett; 2000 Oct; 483(1):57-61. PubMed ID: 11033356
[TBL] [Abstract][Full Text] [Related]
5. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes.
Dean JL; Brook M; Clark AR; Saklatvala J
J Biol Chem; 1999 Jan; 274(1):264-9. PubMed ID: 9867839
[TBL] [Abstract][Full Text] [Related]
6. Strong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor.
Westra J; Doornbos-van der Meer B; de Boer P; van Leeuwen MA; van Rijswijk MH; Limburg PC
Arthritis Res Ther; 2004; 6(4):R384-92. PubMed ID: 15225374
[TBL] [Abstract][Full Text] [Related]
7. 17Beta-estradiol downregulates Kupffer cell TLR4-dependent p38 MAPK pathway and normalizes inflammatory cytokine production following trauma-hemorrhage.
Hsieh YC; Frink M; Thobe BM; Hsu JT; Choudhry MA; Schwacha MG; Bland KI; Chaudry IH
Mol Immunol; 2007 Mar; 44(9):2165-72. PubMed ID: 17182102
[TBL] [Abstract][Full Text] [Related]
8. Dobutamine modulates lipopolysaccharide-induced macrophage inflammatory protein-1alpha and interleukin-8 production in human monocytes.
Li CY; Tsai CS; Hsu PC; Wu CT; Wong CS; Ho ST
Anesth Analg; 2003 Jul; 97(1):210-5, table of contents. PubMed ID: 12818968
[TBL] [Abstract][Full Text] [Related]
9. Monocyte intracellular cytokine production during human endotoxaemia with or without a second in vitro LPS challenge: effect of RWJ-67657, a p38 MAP-kinase inhibitor, on LPS-hyporesponsiveness.
Faas MM; Moes H; Fijen JW; Muller Kobold AC; Tulleken JE; Zijlstra JG
Clin Exp Immunol; 2002 Feb; 127(2):337-43. PubMed ID: 11876759
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide post-transcriptionally up-regulates LPS-induced IL-8 expression through p38 MAPK activation.
Ma P; Cui X; Wang S; Zhang J; Nishanian EV; Wang W; Wesley RA; Danner RL
J Leukoc Biol; 2004 Jul; 76(1):278-87. PubMed ID: 15178710
[TBL] [Abstract][Full Text] [Related]
11. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence.
Underwood DC; Osborn RR; Kotzer CJ; Adams JL; Lee JC; Webb EF; Carpenter DC; Bochnowicz S; Thomas HC; Hay DW; Griswold DE
J Pharmacol Exp Ther; 2000 Apr; 293(1):281-8. PubMed ID: 10734180
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages.
Smith SJ; Fenwick PS; Nicholson AG; Kirschenbaum F; Finney-Hayward TK; Higgins LS; Giembycz MA; Barnes PJ; Donnelly LE
Br J Pharmacol; 2006 Oct; 149(4):393-404. PubMed ID: 16953188
[TBL] [Abstract][Full Text] [Related]
13. Distinctive calcineurin-dependent (FK506-sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES vs IL-2 and TNF-alpha by activated human T cells.
Staruch MJ; Camacho R; Dumont FJ
Cell Immunol; 1998 Dec; 190(2):121-31. PubMed ID: 9878113
[TBL] [Abstract][Full Text] [Related]
14. Geldanamycin inhibits the production of inflammatory cytokines in activated macrophages by reducing the stability and translation of cytokine transcripts.
Wax S; Piecyk M; Maritim B; Anderson P
Arthritis Rheum; 2003 Feb; 48(2):541-50. PubMed ID: 12571865
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 13 inhibits macrophage inflammatory protein-1 alpha production from human alveolar macrophages and monocytes.
Berkman N; John M; Roesems G; Jose P; Barnes PJ; Chung KF
Am J Respir Cell Mol Biol; 1996 Sep; 15(3):382-9. PubMed ID: 8810643
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the mitogen activated protein kinase, p38 alpha, prevents proinflammatory cytokine induction by human adherent mononuclear leukocytes in response to lipid loading.
Feng Y; Schreiner GF; Chakravarty S; Liu DY; Joly AH
Atherosclerosis; 2001 Oct; 158(2):331-8. PubMed ID: 11583711
[TBL] [Abstract][Full Text] [Related]
17. Suppression of lipopolysaccharide-induced cytokine production of gingival fibroblasts by a soybean, Kunitz trypsin inhibitor.
Kobayashi H; Yoshida R; Kanada Y; Fukuda Y; Yagyu T; Inagaki K; Kondo T; Kurita N; Suzuki M; Kanayama N; Terao T
J Periodontal Res; 2005 Dec; 40(6):461-8. PubMed ID: 16302924
[TBL] [Abstract][Full Text] [Related]
18. Role of p38 MAPK in LPS induced pro-inflammatory cytokine and chemokine gene expression in equine leukocytes.
Neuder LE; Keener JM; Eckert RE; Trujillo JC; Jones SL
Vet Immunol Immunopathol; 2009 Jun; 129(3-4):192-9. PubMed ID: 19070370
[TBL] [Abstract][Full Text] [Related]
19. RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.
Wadsworth SA; Cavender DE; Beers SA; Lalan P; Schafer PH; Malloy EA; Wu W; Fahmy B; Olini GC; Davis JE; Pellegrino-Gensey JL; Wachter MP; Siekierka JJ
J Pharmacol Exp Ther; 1999 Nov; 291(2):680-7. PubMed ID: 10525088
[TBL] [Abstract][Full Text] [Related]
20. p38 Mitogen-activated protein kinase regulates IL-8 expression in human pulmonary vascular endothelial cells.
Hashimoto S; Matsumoto K; Gon Y; Maruoka S; Takeshita I; Hayashi S; Koura T; Kujime K; Horie T
Eur Respir J; 1999 Jun; 13(6):1357-64. PubMed ID: 10445612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
